Imatinib plasma levels: correlation with clinical benefit in GIST patients.
Widmer
N
N
Decosterd
L A
LA
Csajka
C
C
Montemurro
M
M
Haouala
A
A
Leyvraz
S
S
Buclin
T
T
D000418:Albumins / Q000378:metabolism; D000970:Antineoplastic Agents / Q000097:blood* / Q000493:pharmacokinetics / Q000627:therapeutic use; D001549:Benzamides; D004305:Dose-Response Relationship, Drug; D046152:Gastrointestinal Stromal Tumors / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism; D005838:Genotype; D006023:Glycoproteins / Q000378:metabolism; D006801:Humans; D000068877:Imatinib Mesylate; D010879:Piperazines / Q000097:blood* / Q000493:pharmacokinetics / Q000627:therapeutic use; D011743:Pyrimidines / Q000097:blood* / Q000493:pharmacokinetics / Q000627:therapeutic use; D016896:Treatment Outcome
D000418:Albumins; D000970:Antineoplastic Agents; D001549:Benzamides; D006023:Glycoproteins; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate